Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 284 | 141 | 132 | 70,570 | 75 |
| Gross Profit | 284 | 141 | 132 | 70,570 | 75 |
| Operating Expenses | 126,552 | 116,310 | 122,881 | 110,583 | 106,842 |
| Operating Income | -126,268 | -116,169 | -122,749 | -40,013 | -106,767 |
| Interest Expense | 8,307 | 3,462 | 3,324 | 560 | 514 |
| Other Income | 7,456 | 14,730 | 5,718 | 5,974 | 6,546 |
| Pre-tax Income | -127,119 | -104,901 | -120,355 | -34,599 | -100,735 |
| Net Income Continuous | -127,119 | -104,901 | -120,355 | -34,599 | -100,735 |
| Net Income | $-127,119 | $-104,901 | $-120,355 | $-34,599 | $-100,735 |
| EPS Basic Total Ops | -1.05 | -0.90 | -1.11 | -0.34 | -1.00 |
| EPS Basic Continuous Ops | -1.18 | -1.03 | -1.31 | -0.42 | -1.23 |
| EPS Diluted Total Ops | -1.05 | -0.90 | -1.11 | -0.34 | -1.00 |
| EPS Diluted Continuous Ops | -1.18 | -1.03 | -1.31 | -0.42 | -1.23 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.90 | -1.08 | -0.34 | -1.00 |
| EBITDA(a) | $-127,602 | $-117,905 | $-124,382 | $-41,036 | $-108,206 |